Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
about
Review of photoacoustic flow imaging: its current state and its promisesAn introduction to molecular imaging in radiation oncology: a report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR)Improving tumour heterogeneity MRI assessment with histograms.Sensitivity of MRI tumor biomarkers to VEGFR inhibitor therapy in an orthotopic mouse glioma modelMRI-based prediction of pulsed high-intensity focused ultrasound effect on tissue transport in rabbit muscleFunctional magnetic resonance: biomarkers of response in breast cancerMRI in the early identification and classification of high-risk atherosclerotic carotid plaques.Golden-angle radial sparse parallel MRI: combination of compressed sensing, parallel imaging, and golden-angle radial sampling for fast and flexible dynamic volumetric MRI.Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications.Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique.Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy.Comparison of cerebral blood volume maps generated from T2* and T1 weighted MRI data in intra-axial cerebral tumours.MRI for identification of progression in brain tumors: from morphology to function.Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.Can DCEMRI assess the effect of green tea on the angiogenic properties of rodent prostate tumors?Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in miceFunctional and molecular imaging with MRI: potential applications in paediatric radiology.DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibilitySynthesis and evaluation of a polydisulfide with Gd-DOTA monoamide side chains as a biodegradable macromolecular contrast agent for MR blood pool imagingMagnetic resonance in the detection of breast cancers of different histological types.Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study.Functional MRI of the kidney: tools for translational studies of pathophysiology of renal disease.Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRIQuantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer.Feasibility of high temporal resolution breast DCE-MRI using compressed sensing theory.Temporal/spatial resolution improvement of in vivo DCE-MRI with compressed sensing-optimized FLASHNovel nano-sized MR contrast agent mediates strong tumor contrast enhancement in an oncogene-driven breast cancer modelThe use of dynamic tracer concentration in veins for quantitative DCE-MRI kinetic analysis in head and neck.Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.Preoperative staging of colorectal cancer--computed tomography and magnetic resonance imaging.Physiologic characterization of inflammatory arthritis in a rabbit model with BOLD and DCE MRI at 1.5 Tesla.Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection.Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study.Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.The development and application of functional nuclear magnetic resonance to in vivo therapeutic anticancer research: 2002 Sir Godfrey Hounsfield lecture delivered at the President's Day, Manchester.Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial.MRI for assessing antivascular cancer treatments.
P2860
Q26774025-42CE34B1-FC12-4A22-92F3-36E87A3F4988Q27002845-8B3961D2-7DE8-4FD0-A0FE-ABFBFAD2561EQ27693208-5ABF1E39-C764-458B-9585-A792ADD2C8FEQ28742242-C4357861-1855-4DC9-B62B-BC93E5F8CCC4Q30427143-4ADCB500-8944-49D4-B389-3F42CE531F2DQ30474460-BF150D55-3F6E-496A-9136-A5E98A943F85Q30478391-32E092C1-50E5-45FE-9218-44DEDFF63D5DQ30576373-BCC71927-33CA-4534-A34C-82B1DB7373FBQ30708273-532A65DA-2342-4D21-9A58-CEB4BE9A44C3Q30988445-7AE23F94-7DF1-4663-8152-91218B00F853Q30992467-92DA95B2-9C0B-48DC-9382-5EF4DD89E8B7Q31030824-6F0CCF12-BB40-40F9-8B4A-41DB29ABB05FQ31032006-F5776298-1781-422F-8F62-11101254BFA8Q31101076-EC7870C0-AB67-45E7-BF77-78F3895A02B6Q33377547-4590F612-EC1B-4EF4-BCF4-7C6559EC5F13Q33486630-FEC3FD2B-DB7B-490E-80B7-67FC34AB15D4Q33489265-9E53F854-1835-487D-B604-AE3F10A339F7Q33584677-F8212320-0F7D-404F-83CA-097765DB21E6Q33726910-B6E53255-4088-4874-AD65-B91DF67D9518Q33759248-4DD8BA12-011E-4E8C-8C0C-08E6CF3870ABQ33768662-B9DEC968-C8BE-4202-89D3-EABCE8D9467BQ33873362-2F07D4B0-6752-4A9D-B6AA-F6DD61883867Q33997699-0E53D7CC-C735-4387-AFCD-C6FA74D1BE46Q34055638-C794DE17-A2B4-4364-A4AB-38AD023980ECQ34089545-0564AB8D-7382-4FA5-9A80-34E12825C79EQ34138733-7EA9A750-AB07-4EB0-BCCA-DABA1B0C8DD7Q34156025-78E02F8C-5B2A-4880-AB7E-CF57B32AF9A0Q34215586-6316EDD0-2EBA-4063-B5E6-9FF86E1E2EC7Q34306808-15D2B6D2-4FB8-4C0A-95A8-D057E05141FFQ34635573-249B036E-DC8F-4939-93E6-6278B98725E7Q34860290-6D677B0B-9C2D-4EC0-9087-BA6B8ADBF97CQ34952709-E276C750-ACC5-493F-BEB1-205618F2E091Q35111164-796D54FD-A8CB-47F1-936E-900BE2817D9CQ35237979-5B911085-BD85-4562-8448-B670F39853E9Q35659383-9B35E226-F823-4539-ABFA-99AAF17BA36AQ35676964-D497E0DE-AE7F-4672-8067-E4203B2E959CQ35703167-313A5567-B6F2-4BE3-9985-18DF03458EA5Q35755404-C64E863E-799F-4C10-A136-AC8E14121F90Q35777339-FAD14059-08BE-4A4E-B8ED-4708917FA8C6Q35905005-03EAA778-1E1B-410F-9045-F4A1E9F9A31B
P2860
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@ast
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@en
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@nl
type
label
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@ast
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@en
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@nl
prefLabel
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@ast
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@en
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@nl
P2860
P356
P1476
Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions.
@en
P2093
Anwar R Padhani
P2860
P304
P356
10.1002/JMRI.10176
P577
2002-10-01T00:00:00Z